PEAK6 Investments’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,438
Closed -$316K 4686
2023
Q1
$264K Sell
4,438
-6,770
-60% -$376K ﹤0.01% 2905
2022
Q4
$547K Sell
11,208
-56,237
-83% -$2.6M ﹤0.01% 2434
2022
Q3
$3.48M Buy
+67,445
New +$4M 0.01% 1095
2022
Q2
Sell
-17,497
Closed -$1.22M 5254
2022
Q1
$1.5M Sell
17,497
-6,568
-27% -$540K ﹤0.01% 2131
2021
Q4
$1.97M Buy
24,065
+14,765
+159% +$1.08M ﹤0.01% 1908
2021
Q3
$618K Buy
+9,300
New +$660K ﹤0.01% 3040
2021
Q1
Sell
-24,984
Closed -$998K 5530
2020
Q4
$998K Sell
24,984
-20,802
-45% -$671K ﹤0.01% 2485
2020
Q3
$1.12M Buy
45,786
+13,598
+42% +$347K ﹤0.01% 2163
2020
Q2
$583K Sell
32,188
-10,808
-25% -$213K ﹤0.01% 2538
2020
Q1
$619K Sell
42,996
-15,639
-27% -$449K ﹤0.01% 1911
2019
Q4
$2.23M Buy
58,635
+6,675
+13% +$200K 0.01% 1019
2019
Q3
$1.15M Sell
51,960
-40,824
-44% -$870K 0.01% 1666
2019
Q2
$1.92M Buy
92,784
+49,181
+113% +$1.13M 0.01% 1326
2019
Q1
$1.26M Buy
43,603
+82
+0.2% +$2.02K 0.01% 1669
2018
Q4
$746K Buy
+43,521
New +$1.05M ﹤0.01% 2018

Other funds holding THC

PEAK6 Investments's THC Position: Q2 2023 in Review

PEAK6 Investments sold out of Tenet Healthcare (THC) in Q2 2023, closing a stake of 4,438 shares — an estimated $316K sold.

PEAK6 Investments first reported a position in THC in Q4 2018 and held it in 15 quarters. The position peaked at $3.48M in Q3 2022. 416 funds tracked by Wall St. Rank hold THC as of Q2 2023.

  • PEAK6 Investments reported no remaining Tenet Healthcare position as of Q2 2023 after selling out during the quarter.
  • PEAK6 Investments sold 4,438 Tenet Healthcare shares in Q2 2023, an estimated $316K.
  • PEAK6 Investments first reported a position in Tenet Healthcare in Q4 2018 and held it in 15 quarters.
  • PEAK6 Investments's Tenet Healthcare position peaked at $3.48M in Q3 2022.
  • 416 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2023.

Based on PEAK6 Investments's 13F filing for Q2 2023, filed 11 Aug 2023.